US20070281041A1

Compositions and Methods Involving MDA-7 for the Treatment of Cancer

University of Texas System

Abstract

The present invention concerns methods and compositions involving MDA-7 protein or an MDA-7-encoding nucleic acid and an EGFR inhibitor for the treatment of cancer. In certain embodiments, the invention specifically concerns a small molecule tyrosine kinase inhibitor, for example, erlotinib, as …

University: University of Texas System
Assignee: The Board Of Regents Of The University Of Texas System
Inventor: Rajagopal Ramesh
Priority date: March 02, 2004
Filing date: April 27, 2007
Publication date: December 06, 2007
Language: en
PDF source: https://patentimages.storage.googleapis.com/9e/e4/dc/fc0ea6415637b1/US20070281041A1.pdf
Metadata fetched: August 29, 2026 00:18